Edition:
United Kingdom

China Regenerative Medicine International Ltd (8158.HK)

8158.HK on Hong Kong Stock

0.17HKD
8:47am BST
Change (% chg)

HK$0.01 (+7.50%)
Prev Close
HK$0.16
Open
HK$0.17
Day's High
HK$0.17
Day's Low
HK$0.17
Volume
23,250
Avg. Vol
1,030,100
52-wk High
HK$3.60
52-wk Low
HK$0.15

Latest Key Developments (Source: Significant Developments)

China Regenerative Medicine International Says Qtrly Loss Attributable HK$36.7 Mln
Wednesday, 15 May 2019 

May 15 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::QTRLY LOSS ATTRIBUTABLE HK$36.7 MILLION VERSUS LOSS OF 53.4 MILLION.  Full Article

China Regenerative Medicine International To Place Up To 3.52 Bln Shares
Friday, 26 Apr 2019 

April 26 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::TO PLACE UP TO 3.52 BILLION SHARES AT PLACING PRICE OF HK$0.025 PER SHARE.NET PROCEEDS FROM PLACING WILL BE ABOUT HK$86.6 MILLION.  Full Article

China Regenerative Medicine International Expects FY Loss Attributable
Monday, 11 Mar 2019 

March 11 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::GROUP IS EXPECTED TO RECORD A SIGNIFICANT LOSS ATTRIBUTABLE FOR YEAR.  Full Article

Baolingbao Biology's Unit Signs Agreement To Acquire 11.4 Pct Stake In China Regenerative Medicine
Thursday, 25 Jan 2018 

Jan 25 (Reuters) - Baolingbao Biology Co Ltd <002286.SZ>::SAYS UNIT SIGNS AGREEMENT TO BUY 2.0 BILLION SHARES IN CHINA REGENERATIVE MEDICINE INTERNATIONAL <<<8158.HK>>>, OR 11.4 PERCENT STAKE, FOR HK$360 MILLION ($46.05 million).  Full Article

China Regenerative Medicine International Entered Agreement With Shanghai Lingang Songjiang High-Tech Industry Development
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::ENTERED COOPERATION FRAMEWORK AGREEMENT WITH SHANGHAI LINGANG SONGJIANG HIGH-TECH INDUSTRY DEVELOPMENT.AGREEMENT FOR DEVELOPMENT & CONSTRUCTION OF SCIENCE OASIS SITE​.  Full Article

China Regenerative Medicine International To By ‍Lung Hang Investments For HK$3.6 Bln-HK$$3.8 Bln​
Monday, 11 Dec 2017 

Dec 11 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::CO TO BY ‍LUNG HANG INVESTMENTS FROM SACRED HEART HEALTHCARE LTD PARTNERSHIP FOR HK$3.6 BILLION TO HK$3.8 BILLION​.  Full Article

China Regenerative Medicine International Says Qtrly Revenue Hk$89 Million
Friday, 8 Dec 2017 

Dec 8 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::QTRLY REVENUE HK$89 MILLION VERSUS HK$25.5 MILLION ‍​.QTRLY NET LOSS HK$63.3 MILLION VERSUS NET LOSS OF HK$61.8 MLN‍​.  Full Article

China Regenerative Medicine International Says ‍Wong Sai Hung Resigned As Vice-Chairman
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::WONG SAI HUNG RESIGNED AS EXECUTIVE DIRECTOR AND VICE-CHAIRMAN OF BOARD​.  Full Article

China Regenerative Medicine International says unit to sell Shaanxi Aimiya​ to third party
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::Unit entered into deal to sell 100 percent stake in Shaanxi Aimiya​ to third party buyer.Estimated gain on disposal of about RMB28.6 million to be recorded in group's FY ending Dec. 31, 2017​.Unit to also sell loan to third party purchaser; consideration for SPA and loan RMB40 million​.  Full Article

China Regenerative Medicine International say Dai Yumin acquired 40 pct stake in All Favour
Thursday, 21 Sep 2017 

Sept 21 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>:Voluntary announcement Dai Yumin acquired 40% All Favour and became the sole beneficial owner of All Favour.Deal at a consideration of approximately HK$340 million.  Full Article

No consensus analysis data available.